Scientists unravel how psychedelic drugs interact with cell membranes, revealing a possible mechanism behind serotonin 2A receptor signaling

Psychedelic drugs may influence brain signaling not only by binding to the serotonin 2A receptor but also by interacting directly with the cell membrane around it. Membrane lipids appear to shape how that receptor changes form, clusters, and transmits signals, offering a more detailed picture of how classic psychedelics produce their effects. Researchers connect this membrane-level behavior to compounds such as LSD, psilocybin, DMT, and mescaline, which all act through 5-HT2A pathways but can produce different subjective and biological responses. The proposed mechanism helps explain why receptor activation alone does not fully account for psychedelic effects and why the local membrane environment matters. This line of work could improve drug design by identifying ways to tune therapeutic effects while reducing unwanted outcomes. Better understanding of receptor-membrane dynamics may support the development of next-generation psychedelic medicines for psychiatric treatment.